Navigation Links
Informed Medical Communications Adopts Newly Enhanced Compliance Policy
Date:6/23/2008

EDISON, N.J., June 23 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced adoption of an enhanced compliance policy and the appointment of Dr. Jaime Nguyen as Medical Director/ Compliance Officer (CO). The policy specifically outlines the role of the CO as well as methods for handling written policies/procedures, training/education, internal monitoring/auditing, reporting/lines of communication, and prompt response and corrective action for violations and detected problems. "The changes reflect IMC's commitment to compliance with the laws, regulations, and guidelines that govern pharmaceutical promotional and marketing activities," said Steve Budd, CEO of IMC. "Our ongoing investment in this critical competency will enable us to partner more closely with our clients to ensure that the medical communications programs we execute on their behalf meet the highest standards for promotional compliance."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

Dr. Nguyen was appointed to this position following two years of distinguished service as a moderator on numerous IMC programs. Nguyen holds an MD from MSIH and Columbia University Medical Center, an MPH from the University of Pittsburgh, and an MS in Medicinal Chemistry and Pharmacology from the University of Toledo. Additionally, Nguyen is a certified Pharmaceutical, Biotech and Medical Device Compliance Officer. Prior to joining IMC in 2006, Nguyen had over 10 years of experience in the areas of pharmacology and drug design, medicine and public health, and healthcare analysis. She also held numerous international clinical leadership roles across multiple therapeutic areas and served on two federal advisory committees while working for the Department of Health and Human Services.

"In the current highly regulated environment, and consistent with our ongoing focus on mitigating risk for our clients, a comprehensive Compliance Policy and dedicated CO are essential," noted Kathleen Bresette, President of The Peer Group (an IMC company). "We are delighted to have someone with Jaime's qualifications and enthusiasm supporting IMC and our clients in this capacity."

IMC's Compliance Policy may be found on the IMC website.

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Leading Through Dialogue, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
2. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
3. Informed Medical Communications Hires New Vice President of Marketing
4. Informed Medical Communications Appoints New Chief Financial Officer
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... San Francisco, CA (PRWEB) , ... February 21, ... ... is pleased to announce that Dr. Trevor Heritage has joined its executive team ... a revolutionary system designed to provide insights to help improve the diagnosis and ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... GMP cell therapy manufacturing facility at its headquarters laboratory in Poway, California. ... utilizing the experience of both in-house personnel and consultants, VetStem constructed and validated ...
(Date:2/21/2017)... a returning partner of the Amgen Tour of California , ... of the men,s and women,s events for the next five editions ... of California will mark the start of ... cycling teams in the world racing from Northern to ... from Heart Disease TM Women,s Race empowered with SRAM ...
(Date:2/21/2017)... 2017   Invitae Corporation (NYSE: NVTA), one ... that members of the company,s management team will present ... Conference on Monday, March 6, 2017 at approximately 4:00 ... Boston, Massachusetts . The live, ... visiting the investors section of the company,s website at ...
Breaking Biology Technology:
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
Breaking Biology News(10 mins):